À propos de cet article
Publié en ligne: 21 janv. 2025
Pages: 187 - 193
DOI: https://doi.org/10.2478/orvtudert-2022-0013
Mots clés
© 2022 Sánta Réka et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Cardiomyopathies are primary myocardial disorders that cause systolic and/or diastolic cardiac dysfunction. They are relatively rare in the foetus and neonatal period and carrying a significantly worse prognosis and high mortality. Neonatal cardiomyopathies exhibit considerable aetiological heterogeneity, with various genetic and acquired causes. Acquired cardiomyopathies are typically associated with placental injury or infectious, immune-mediated myocardial damage. Diagnostic evaluation is complicated by the variable clinical presentation. We describe an acquired form of neonatal hypertrophic cardiomyopathy associated with polycythemia identified as a consequence of maternal chronic placental insufficiency.